Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, NTNU - Norwegian University of Science and Technology, Erling Skjalgssons gt. 1, 7491, Trondheim, Norway.
Department of Neuromedicine and Movement Science, Faculty of Medicine and Health Sciences, NTNU - Norwegian University of Science and Technology, Trondheim, Norway.
Acta Neurochir (Wien). 2021 Jul;163(7):1911-1920. doi: 10.1007/s00701-020-04608-y. Epub 2020 Oct 21.
Glioblastomas (GBMs) are known for having a vastly heterogenous histopathology. Several studies have shown that GBMs can be histologically undergraded due to sampling errors of small tissue samples. We sought to explore to what extent histological features in GBMs are dependent on the amount of viable tissue on routine slides from both biopsied and resected tumors.
In 106 newly diagnosed GBM patients, we investigated associations between the presence or degree of 24 histopathological and two immunohistochemical features and the tissue amount on hematoxylin-eosin (HE) slides. The amount of viable tissue was semiquantitatively categorized as "sparse," "medium," or "substantial" for each case. Tissue amount was also assessed for associations with MRI volumetrics and the type of surgical procedure.
About half (46%) of the assessed histological and immunohistochemical features were significantly associated with tissue amount. The significant features were less present or of a lesser degree when the tissue amount was smaller. Among the significant features were most of the features relevant for diffuse astrocytic tumor grading, i.e., small necroses, palisades, microvascular proliferation, atypia, mitotic count, and Ki-67/MIB-1 proliferative index (PI).
A substantial proportion of the assessed histological features were at risk of being underrepresented when the amount of viable tissue on HE slides was limited. Most of the grading features were dependent on tissue amount, which underlines the importance of considering sampling errors in diffuse astrocytic tumor grading. Our findings also highlight the importance of adequate tissue collection to increase the quality of diagnostics and histological research.
胶质母细胞瘤(GBM)以其具有广泛的异质性组织病理学而闻名。多项研究表明,由于小组织样本的采样误差,GBM 可能在组织学上被低估。我们试图探讨 GBM 中的组织学特征在多大程度上依赖于活检和切除肿瘤的常规切片中的有活力组织的数量。
在 106 名新诊断的 GBM 患者中,我们研究了 24 种组织病理学和两种免疫组织化学特征的存在或程度与苏木精-伊红(HE)切片上的组织量之间的关系。每个病例的有活力组织量均被半定量地分为“稀疏”、“中等”或“丰富”。还评估了组织量与 MRI 体积和手术类型的关联。
评估的组织学和免疫组织化学特征中约有一半(46%)与组织量显著相关。当组织量较小时,这些特征的存在或程度较小。显著相关的特征包括大多数与弥漫性星形细胞瘤分级相关的特征,即小坏死、栅栏状、微血管增生、异型性、有丝分裂计数和 Ki-67/MIB-1 增殖指数(PI)。
当 HE 切片上有活力的组织量有限时,评估的组织学特征中有相当一部分有被低估的风险。大多数分级特征依赖于组织量,这强调了在弥漫性星形细胞瘤分级中考虑采样误差的重要性。我们的研究结果还突出了适当组织采集以提高诊断和组织学研究质量的重要性。